Last 7 days
-63.5%
Last 30 days
-95%
Last 90 days
-91.4%
Trailing 12 Months
-98.6%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-06-02 | Kieftenbeld Hermanus | sold | -19,949 | 0.95 | -20,999 | chief financial officer |
2023-04-19 | Qi Lisa | acquired | - | - | 10,537 | - |
2023-04-19 | Panchadsaram Ryan | acquired | - | - | 9,667 | - |
2023-04-19 | DOERR L JOHN | acquired | - | - | 11,600 | - |
2023-04-19 | MCCANN JAMES F | acquired | - | - | 13,437 | - |
2023-04-05 | ALVAREZ EDUARDO | sold | -284,305 | 1.2288 | -231,368 | chief operating officer |
2023-04-04 | ALVAREZ EDUARDO | acquired | - | - | 492,000 | chief operating officer |
2023-01-20 | Qi Lisa | acquired | - | - | 7,532 | - |
2023-01-20 | Panchadsaram Ryan | acquired | - | - | 7,947 | - |
2023-01-20 | DOERR L JOHN | acquired | - | - | 8,292 | - |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -54.64 | -144,129 | 75,449 | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -5.49 | -115,650 | 291,229 | -% |
2023-08-17 | SILVERBACK ASSET MANAGEMENT LLC | new | - | 206,000 | 206,000 | 0.03% |
2023-08-16 | GTS SECURITIES LLC | new | - | 11,928 | 11,928 | -% |
2023-08-16 | Nuveen Asset Management, LLC | unchanged | - | -91,118 | 283,882 | -% |
2023-08-15 | BENJAMIN EDWARDS INC | unchanged | - | - | - | -% |
2023-08-15 | GOLDMAN SACHS GROUP INC | added | 126 | 204,466 | 490,725 | -% |
2023-08-15 | LAZARD ASSET MANAGEMENT LLC | reduced | -91.57 | -3,778,000 | 257,000 | -% |
2023-08-15 | ALLIANCEBERNSTEIN L.P. | added | 67.12 | 67,103 | 319,678 | -% |
2023-08-15 | Gordian Capital Singapore Pte Ltd | sold off | -100 | -7,000 | - | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Sep 20, 2023 | foris ventures, llc | 30.2% | 122,034,555 | SC 13D/A | |
Aug 10, 2023 | foris ventures, llc | 29.9% | 120,499,897 | SC 13D/A | |
Aug 03, 2023 | foris ventures, llc | 29.9% | 120,480,436 | SC 13D/A | |
Jun 30, 2023 | foris ventures, llc | 29.9% | 120,385,914 | SC 13D/A | |
Jun 09, 2023 | foris ventures, llc | 29.9% | 120,319,193 | SC 13D/A | |
Jun 07, 2023 | dsm international b.v. | - | 0 | SC 13D/A | |
May 24, 2023 | foris ventures, llc | 29.9% | 120,177,411 | SC 13D/A | |
Mar 17, 2023 | foris ventures, llc | 30.1% | 119,877,165 | SC 13D/A | |
Feb 14, 2023 | cvi investments, inc. | 4.9% | 18,163,117 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 5.84% | 21,211,189 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 20, 2023 | 3 | Insider Trading | |
Sep 20, 2023 | SC 13D/A | 13D - Major Acquisition | |
Sep 19, 2023 | 8-K | Current Report | |
Sep 08, 2023 | 25-NSE | 25-NSE | |
Aug 31, 2023 | 8-K | Current Report | |
Aug 17, 2023 | 3 | Insider Trading | |
Aug 17, 2023 | 3 | Insider Trading | |
Aug 15, 2023 | 8-K | Current Report | |
Aug 11, 2023 | 8-K | Current Report | |
Aug 10, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
LYB | 31.0B | 43.0B | -2.41% | 27.87% | 14.66 | 0.72 | -19.65% | -61.23% |
IFF | 17.5B | 11.9B | 2.30% | -30.31% | -7.96 | 1.47 | -6.11% | -441.15% |
WLK | 15.4B | 13.9B | -6.90% | 40.29% | 11.56 | 1.11 | -8.20% | -53.46% |
RPM | 12.1B | 7.3B | -5.83% | 8.92% | 25.29 | 1.67 | 8.18% | -2.60% |
PPG | - | 17.9B | -7.28% | 13.84% | - | - | 1.96% | 21.57% |
MID-CAP | ||||||||
AXTA | - | 5.1B | -4.22% | 12.94% | - | - | 9.03% | 9.70% |
OLN | 5.9B | 7.8B | -16.23% | 4.63% | 7.32 | 0.76 | -20.33% | -46.41% |
NEU | 4.4B | 2.8B | -0.14% | 53.03% | 12.43 | 1.58 | 7.02% | 79.95% |
SXT | 2.6B | 1.5B | 3.49% | -17.17% | 19.26 | 1.76 | 2.92% | -2.93% |
SMALL-CAP | ||||||||
FF | 319.0M | 395.4M | -0.13% | 21.63% | 7.61 | 0.81 | 6.42% | 107.62% |
WLKP | - | 1.4B | -3.36% | -0.27% | - | - | -5.70% | -3.36% |
AMRS | 29.3M | 268.2M | -95.00% | -98.59% | -0.05 | 0.11 | 20.46% | -592.58% |
-48.6%
-50.0%
-62.3%
-75.8%
100%
96.5%
96.5%
Y-axis is the maximum loss one would have experienced if Amyris was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 |
Revenue | -0.6% | 268,221,000 | 269,847,000 | 258,821,000 | 235,558,000 | 222,667,000 | 341,817,000 | 356,785,000 | 343,177,000 | 320,866,000 | 173,137,000 | 133,929,000 | 134,624,000 | 167,313,000 | 152,557,000 | 128,392,000 | 107,754,000 | 60,119,000 | 63,604,000 | 127,821,000 | 137,703,000 | 148,324,000 |
Costs and Expenses | 7.1% | 898,173,000 | 838,830,000 | 803,838,000 | 719,242,000 | 617,799,000 | 519,443,000 | 408,532,000 | 356,161,000 | 319,542,000 | 296,559,000 | 286,252,000 | 276,939,000 | 271,578,000 | 274,447,000 | 267,063,000 | 246,294,000 | 222,746,000 | 200,187,000 | 182,799,000 | 178,817,000 | 184,637,000 |
S&GA Expenses | -2.2% | 482,583,000 | 493,629,000 | 453,126,000 | 399,052,000 | 326,805,000 | 257,811,000 | 199,130,000 | 166,816,000 | 142,979,000 | 137,071,000 | 134,968,000 | 129,988,000 | 130,347,000 | 126,586,000 | 118,565,000 | 112,463,000 | 101,055,000 | 90,902,000 | 84,393,000 | 72,608,000 | 69,103,000 |
R&D Expenses | 0.4% | 110,622,000 | 110,215,000 | 105,958,000 | 101,002,000 | 97,315,000 | 94,289,000 | 88,968,000 | 83,341,000 | 77,882,000 | 71,676,000 | 67,655,000 | 68,490,000 | 70,747,000 | 71,460,000 | 74,876,000 | 72,289,000 | 68,736,000 | 68,722,000 | 63,360,000 | 62,100,000 | 60,680,000 |
EBITDA | -16.5% | -584,044,000 | -501,519,000 | -313,100,000 | -182,997,000 | -62,647,000 | -244,733,000 | -391,486,000 | -376,422,000 | -486,121,000 | -274,276,000 | -232,067,000 | -260,797,000 | -196,649,000 | -178,892,000 | - | - | - | - | - | - | - |
EBITDA Margin | -17.2% | -2.18 | -1.86 | -1.21 | -0.78 | -0.28 | -0.72 | -1.10 | -1.10 | -1.52 | -1.58 | -1.73 | -1.94 | -1.18 | -1.17 | - | - | - | - | - | - | - |
Interest Expenses | 31.2% | 32,453,000 | 24,733,000 | 27,604,000 | 25,636,000 | 25,055,000 | 25,605,000 | 21,061,000 | 23,367,000 | 38,762,000 | 47,951,000 | 55,804,000 | 66,034,000 | 61,133,000 | 58,665,000 | 58,573,000 | 50,896,000 | 45,259,000 | 42,703,000 | 36,600,000 | 35,153,000 | 34,876,000 |
Earnings Before Taxes | -17.1% | -630,997,000 | -538,625,000 | -351,102,000 | -218,064,000 | -92,187,000 | -272,311,000 | -415,396,000 | -402,317,000 | -526,900,000 | -323,850,000 | -295,060,000 | -333,084,000 | -263,233,000 | -242,138,000 | -211,958,000 | -227,382,000 | -203,676,000 | -230,235,000 | -260,081,000 | -219,807,000 | -204,495,000 |
EBT Margin | -17.9% | -2.35 | -2.00 | -1.36 | -0.93 | -0.44 | -0.82 | -1.18 | -1.19 | -1.66 | -1.91 | -2.20 | -2.47 | -1.57 | -1.59 | - | - | - | - | - | - | - |
Net Income | -17.9% | -622,981,000 | -528,510,000 | -343,796,000 | -215,345,000 | -89,951,000 | -270,969,000 | -418,431,000 | -408,643,000 | -532,339,000 | -331,039,000 | -298,189,000 | -334,595,000 | -264,368,000 | -242,767,000 | -212,491,000 | -227,382,000 | -203,676,000 | -230,235,000 | -183,354,000 | -142,762,000 | -127,760,000 |
Net Income Margin | -18.6% | -2.32 | -1.96 | -1.32 | -0.90 | -0.39 | -0.79 | -1.17 | -1.19 | -1.67 | -1.91 | -2.24 | -2.50 | -1.58 | -1.59 | - | - | - | - | - | - | - |
Free Cashflow | 11.9% | -463,453,000 | -525,894,000 | -575,187,000 | -511,021,000 | -442,426,000 | -181,333,000 | -49,103,000 | -35,216,000 | -20,727,000 | -175,753,000 | -209,279,000 | -209,008,000 | -166,328,000 | -156,933,000 | - | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 |
Assets | -17.6% | 680 | 825 | 754 | 789 | 898 | 954 | 542 | 446 | 327 | 223 | 206 | 268 | 167 | 161 | 128 | 123 | 105 | 128 | 123 | 119 | 118 |
Current Assets | -20.5% | 244 | 306 | 272 | 310 | 471 | 639 | 278 | 349 | 252 | 147 | 131 | 191 | 85.00 | 74.00 | 55.00 | 46.00 | 36.00 | 92.00 | 68.00 | 67.00 | 74.00 |
Cash Equivalents | -82.5% | 11.00 | 64.00 | 19.00 | 100 | 288 | 488 | 115 | 214 | 144 | 30.00 | 38.00 | 100 | 3.00 | 2.00 | 2.00 | 1.00 | 5.00 | 47.00 | 19.00 | 14.00 | 24.00 |
Inventory | -2.6% | 109 | 112 | 129 | 99.00 | 82.00 | 75.00 | 72.00 | 54.00 | 48.00 | 43.00 | 37.00 | 33.00 | 31.00 | 28.00 | 16.00 | 14.00 | 8.00 | 10.00 | 6.00 | 7.00 | 5.00 |
Net PPE | 4.1% | 190 | 182 | 170 | 151 | 125 | 73.00 | 53.00 | 42.00 | 32.00 | 33.00 | 30.00 | 27.00 | 27.00 | 29.00 | 24.00 | 24.00 | 22.00 | 20.00 | 17.00 | 15.00 | 13.00 |
Goodwill | -64.6% | 50.00 | 143 | 127 | 134 | 1.00 | 131 | 129 | 4.00 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Liabilities | 2.7% | 1,328 | 1,293 | 1,159 | 1,033 | 1,024 | 675 | 596 | 528 | 637 | 390 | 285 | 327 | 343 | 411 | 336 | 298 | 337 | 340 | 323 | 368 | 404 |
Current Liabilities | 21.6% | 471 | 387 | 309 | 187 | 266 | 270 | 460 | 95.00 | 147 | 163 | 104 | 129 | 192 | 161 | 159 | 190 | 236 | 212 | 154 | 159 | 111 |
Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | 25.00 | 37.00 | 46.00 | 26.00 | 63.00 | 0.00 | 60.00 | - | - | - | - |
LT Debt, Current | 2.7% | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 25.00 | 1.00 | 56.00 | 55.00 | 31.00 | 43.00 | 77.00 | 45.00 | 65.00 | 79.00 | 129 | 124 | 62.00 | 60.00 | 34.00 |
LT Debt, Non Current | 0.1% | 676 | 675 | 674 | 673 | 672 | 309 | 12.00 | 14.00 | 14.00 | 26.00 | 26.00 | 24.00 | 12.00 | 48.00 | 20.00 | 10.00 | 43.00 | 43.00 | 44.00 | 44.00 | 62.00 |
Shareholder's Equity | - | - | - | - | - | - | 246 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings | -7.6% | -3,100 | -2,880 | -2,730 | -2,568 | -2,458 | -2,357 | -2,395 | -2,362 | -2,377 | -2,086 | -2,000 | -2,000 | -1,843 | -1,755 | -1,676 | -1,617 | -1,579 | -1,521 | -1,367 | -1,298 | -1,300 |
Additional Paid-In Capital | 0.4% | 2,466 | 2,456 | 2,384 | 2,357 | - | 2,657 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding | 1.0% | 369 | 365 | 325 | 321 | 313 | 309 | 301 | 320 | 268 | 245 | 227 | 185 | 155 | 118 | 103 | 93.00 | 78.00 | 77.00 | 56.00 | 55.00 | 51.00 |
Minority Interest | 24.4% | -9.76 | -12.91 | -13.10 | -6.60 | -3.52 | -0.75 | 2.00 | 6.00 | 6.00 | 5.00 | 4.00 | 3.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 |
Cashflow From Operations | 11.9% | -463 | -525 | -575 | -511 | -442 | -181 | -49.10 | -35.22 | -20.73 | -175 | -209 | -209 | -166 | -156 | -133 | -113 | -121 | -109 | -87.97 | -95.49 | -100 |
Share Based Compensation | -11.9% | 43.00 | 49.00 | 48.00 | 45.00 | 41.00 | 33.00 | 26.00 | 20.00 | 15.00 | 14.00 | 12.00 | 12.00 | 13.00 | 13.00 | 13.00 | 13.00 | 11.00 | 9.00 | 8.00 | 7.00 | 6.00 |
Cashflow From Investing | 34.3% | -81.24 | -123 | -142 | -147 | -108 | -64.10 | -43.74 | -12.96 | -14.23 | -12.78 | -13.69 | -12.62 | -11.07 | -13.08 | -15.12 | -14.06 | -13.93 | -12.47 | 43.00 | 48.00 | 50.00 |
Cashflow From Financing | 16.3% | 269 | 231 | 626 | 550 | 698 | 702 | 173 | 166 | 180 | 223 | 260 | 320 | 175 | 125 | 131 | 113 | 114 | 108 | 45.00 | 55.00 | 75.00 |
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2023 | Mar. 31, 2022 | |
Revenue: | ||
Revenue | $ 56,083 | $ 57,709 |
Cost and operating expenses: | ||
Cost of products sold | 51,081 | 48,995 |
Research and development | 26,765 | 26,358 |
Sales, general and administrative | 95,870 | 106,916 |
Change in fair value of acquisition-related contingent consideration | (28,503) | 0 |
Restructuring | 1,013 | 0 |
Impairment | 95,386 | 0 |
Total cost and operating expenses | 241,612 | 182,269 |
Loss from operations | (185,529) | (124,560) |
Other income (expense): | ||
Interest expense | (12,983) | (5,263) |
Gain from change in fair value of derivative instruments | 1,263 | 1,815 |
(Loss) gain from change in fair value of debt | (4,854) | 20,796 |
Other expense, net | (533) | (3,052) |
Total other (expense) income, net | (17,107) | 14,296 |
Loss before income taxes and loss from investment in affiliate | (202,636) | (110,264) |
Benefit from income taxes | 860 | 820 |
Loss from investment in affiliate | 0 | (789) |
Net loss | (201,776) | (110,233) |
Loss attributable to noncontrolling interest | 8,434 | 2,928 |
Net loss attributable to Amyris, Inc. common stockholders | $ (193,342) | $ (107,305) |
Earnings Per Share [Abstract] | ||
Net loss per share attributable to common stockholders, basic (in dollars per share) | $ (0.53) | $ (0.34) |
Weighted-average shares of common stock outstanding used in computing net loss per share of common stock, basic (in shares) | 365,603,738 | 312,896,452 |
Net loss per share attributable to common stockholders, diluted (in dollars per share) | $ (0.53) | $ (0.37) |
Weighted-average shares of common stock outstanding used in computing net loss per share of common stock, diluted (in shares) | 365,603,738 | 323,711,682 |
Renewable Products | ||
Revenue: | ||
Revenue | $ 40,224 | $ 43,465 |
Licenses and Royalties | ||
Revenue: | ||
Revenue | 9,482 | 9,313 |
Collaborations, Grants and Other | ||
Revenue: | ||
Revenue | $ 6,377 | $ 4,931 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 11,245 | $ 64,437 |
Restricted cash | 71 | 71 |
Accounts receivable, net of allowance of $997 and $995 | 36,842 | 45,775 |
Accounts receivable - related party, net of allowance of $0 and $0 | 10,836 | 6,608 |
Contract assets | 3,872 | 806 |
Contract assets - related party | 33,679 | 36,638 |
Inventories | 109,021 | 111,880 |
Prepaid expenses and other current assets | 38,095 | 40,146 |
Total current assets | 243,661 | 306,361 |
Property, plant and equipment, net | 189,645 | 182,224 |
Restricted cash, noncurrent | 6,135 | 6,090 |
Recoverable taxes from Brazilian government entities | 30,189 | 29,472 |
Right-of-use assets under financing leases, net | 147 | 152 |
Right-of-use assets under operating leases, net | 100,721 | 97,216 |
Goodwill | 50,456 | 142,575 |
Intangible assets, net | 45,063 | 46,938 |
Other assets | 13,662 | 13,904 |
Total assets | 679,679 | 824,932 |
Current liabilities: | ||
Accounts payable | 200,067 | 190,486 |
Accrued and other current liabilities | 81,068 | 73,565 |
Financing lease liabilities | 14 | 13 |
Operating lease liabilities | 2,484 | 2,255 |
Contract liabilities | 33 | 26 |
Debt, current portion | 1,968 | 1,916 |
Related party debt, current portion | 185,160 | 118,886 |
Total current liabilities | 470,794 | 387,147 |
Long-term debt, net of current portion | 675,855 | 674,891 |
Related party debt, net of current portion | 77,962 | 97,350 |
Financing lease liabilities, net of current portion | 44 | 48 |
Operating lease liabilities, net of current portion | 90,986 | 86,195 |
Derivative liabilities | 4,140 | 5,403 |
Acquisition-related contingent consideration | 2,241 | 34,555 |
Other noncurrent liabilities | 5,725 | 7,053 |
Total liabilities | 1,327,747 | 1,292,642 |
Commitments and contingencies | ||
Mezzanine equity: | ||
Contingently redeemable common stock | 0 | 5,000 |
Contingently redeemable noncontrolling interest | 26,058 | 28,892 |
Stockholders’ (deficit) equity: | ||
Common stock - $0.0001 par value, 550,000,000 shares authorized as of March 31, 2023 and December 31, 2022; 368,524,240 and 364,745,266 shares issued and outstanding as of March 31, 2023 and December 31, 2022 | 37 | 36 |
Additional paid-in capital | 2,465,802 | 2,455,567 |
Accumulated other comprehensive loss | (56,682) | (64,114) |
Accumulated deficit | (3,073,520) | (2,880,178) |
Total Amyris, Inc. stockholders’ (deficit) equity | (664,363) | (488,689) |
Noncontrolling interest | (9,763) | (12,913) |
Total stockholders' (deficit) equity | (674,126) | (501,602) |
Total liabilities, mezzanine equity and stockholders' (deficit) equity | $ 679,679 | $ 824,932 |